Japan Biomaterials in Healthcare Market Analysis Report [2022-30] I Insights10

Japan Biomaterials in Healthcare Market Analysis

$ 3999

The Japan Biomaterials Healthcare Market is expected to witness growth from $9.71 Bn in 2022 to $27.12 Bn in 2030 with a CAGR of 13.70% for the forecasted year 2022-2030. In Japan, the prevalence of illnesses like gingivitis, tooth decay, oral cancer, halitosis, and dental caries is increasing, which is fueling demand for biomaterials and boosting the country's biomaterial healthcare market. The market is segmented by type and by application. Some key players in this market include: Terumo, Asahi Kasei Corporation, Menicon, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.

ID: IN10JPMD003 CATEGORY: Medical Devices GEOGRAPHY: Japan

Buy Now

Japan Biomaterials in Healthcare Market Executive Analysis

The Japan Biomaterials Healthcare Market size is at around $9.71 Bn in 2022 and is projected to reach $27.12 Bn in 2030, exhibiting a CAGR of 13.70% during the forecast period. From $4,256 in 2018, when it represented 10.75% of GDP, to $4,360 in 2019, when it would reflect 10.74% of GDP, the amount spent on healthcare per person in Japan has increased significantly. The country has a sophisticated and technologically cutting-edge healthcare infrastructure as a result of its high healthcare expenditure. In 2022, there were 12.7 deaths per 1,000 people in Japan. Cancer is the cause of 29% of deaths in Japan.

Japan's biomaterials healthcare market is a quickly expanding industry with the ability to completely transform the country's healthcare system. Synthetic or organic materials known as biomaterials are used to replace or treat diseased or damaged tissues and systems. Numerous medicinal fields, including orthopaedics, cardiology, dentistry, and tissue engineering, use these materials. In orthopaedic surgeries, biomaterials are frequently used to substitute or repair damaged joints, bones, and tissues. In hip, knee, and spinal prostheses, materials like titanium, cobalt-chromium, and polyethylene are frequently used. Heart valves, stents, and pacemakers are all cardiovascular devices that make use of biomaterials. These materials, which are frequently made of ceramics, polymers, or metals, are intended to work with the body's natural cells.

Dental implants use biomaterials to substitute missing teeth or restore teeth that have been damaged. Dental implants frequently consist of materials like titanium, zirconia, and ceramic. By being compatible with the body's native tissues, biomaterials lower the possibility of rejection or negative reactions. Since biomaterials are frequently more resilient than native tissues, implants can last longer and require fewer procedures overall. Biomaterials can speed up the body's natural healing processes, shortening healing periods, and enhance results. Treatment precision and efficacy can be increased by using biomaterials that can be tailored to each patient's unique requirements.

japan biomaterials in healthcare market

Market Dynamics

Market Growth Drivers

In Japan, the prevalence of illnesses like gingivitis, tooth decay, oral cancer, halitosis, and dental caries is increasing, which is fueling demand for biomaterials and boosting the country's biomaterial healthcare market. Examples of biomaterials include metals, polymers, ceramics, and composites. More people are becoming aware of the advantages of using nanomaterials in medicine, including patients and healthcare workers. Without a question, demand will increase as more people become aware of these things. As Japan's population ages, there is a growing demand for biomaterials to treat conditions like osteoarthritis, spine issues, and cardiovascular disease. The Japanese government is committed to promoting the growth of the biofuels industry. This includes grants for research and development, tax breaks, and regulatory assistance, all of which help the Japanese biomaterial healthcare market progress and expand.

Market Restraints

In Japan, the supply of raw materials used to make biomaterials can be constrained, especially for uncommon and specialised materials. Manufacturers may find it challenging to increase output to keep up with demand as a result. The healthcare biomaterials market is extremely competitive, and there are already many well-established companies with significant market share and brand recognition. This can make it difficult for new competitors to find success in the industry.

Competitive Landscape

Key Players

Terumo (JP)
Asahi Kasei Corporation (JP)
Menicon (JP)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Notable Recent Deals

2023: Vaupell Holdings, Inc., a US-based business that specialises in designing and producing high-performance plastic components for the aerospace, medical, and commercial sectors, has been acquired by Sumitomo Bakelite Co. Ltd. The purchase will increase Sumitomo Bakelite's market share in the Japanese healthcare biomaterials industry.

Healthcare Policies and Regulatory Landscape

The Pharmaceuticals and Medical Devices Agency (PMDA) is the primary regulatory agency in charge of regulating the Japanese biomaterials healthcare market. The PMDA is in charge of examining and authorising pharmaceuticals, regenerative medicine products, medical devices, and biomaterials. The Ministry of Health, Labor, and Welfare (MHLW), in addition to PMDA, is crucial to the regulation of the Japanese biomaterials healthcare industry. The MHLW is in charge of establishing requirements for the quality and security of pharmaceuticals, regenerative medicine goods, and medical devices, including biomaterials. The Act on the Safety of Regenerative Medicine is one of the main laws governing the use of biomaterials in healthcare in Japan. This law lays out the rules for the creation and marketing of goods for regenerative medicine, including biomaterials. Before goods are approved for use in patients, the act requires manufacturers to present proof of their products' efficacy and safety. The Good Manufacturing Practice (GMP) regulations are a crucial policy in Japan's biomaterials healthcare industry. These recommendations lay out the quality assurance and control requirements that producers of pharmaceuticals, medical equipment, and biomaterials, among other things, must adhere to.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Japan market in 2019. The growing geriatric population Japanly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.